Ischemic Stroke as a Complex Genetic Disorder

 

 Buy Article Permissions and Reprints

ABSTRACT

Ischemic stroke is a complex genetic disorder, diverse in pathophysiology and clinical presentation. This phenotypic diversity may reflect genotypic diversity. One approach to discovering genetic risk factors has been to study intermediate phenotypes as in carotid intima-media thickness and leukoaraiosis. Intermediate phenotypes can be highly heritable, assessed in stroke-affected and unaffected individuals, and analyzed as quantitative traits. Because there is not a one-to-one relationship between intermediate phenotypes and ischemic stroke, polymorphisms or haplotypes associated with an intermediate phenotype should be validated as risk factors for stroke itself. A complementary approach to gene discovery has been to fractionate the ischemic stroke phenotype into more homogeneous subphenotypes. Family history studies suggest that some subphenotypes like cardioembolic stroke may be less heritable than others.

REFERENCES

• 1 Flossmann E, Schulz U G, Rothwell P M. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke.  Stroke. 2004;  35 212-227
  PubMedGoogle Scholar
• 2 Hassan A, Lansbury A, Catto A J et al.. Angiotensin converting enzyme insertion/deletion genotype is associated with leukoaraiosis in lacunar syndromes.  J Neurol Neurosurg Psychiatry. 2002;  72 343-346
  CrossrefPubMedGoogle Scholar
• 3 Sayed-Tabatabaei F A, Houwing-Duistermaat J J, van Duijn C M et al.. Angiotensin-converting enzyme gene polymorphism and carotid artery wall thickness: a meta-analysis.  Stroke. 2003;  34 1634-1639
  CrossrefPubMedGoogle Scholar
• 4 Carmelli D, DeCarli C, Swan G E et al.. Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins.  Stroke. 1998;  29 1177-1181
  PubMedGoogle Scholar
• 5 Turner S T, Jack C R, Fornage M et al.. Heritability of leukoaraiosis in hypertensive sibships.  Hypertension. 2004;  43 483-487
  CrossrefPubMedGoogle Scholar
• 6 Atwood L D, Wolf P A, Heard-Costa N L et al.. Genetic variation in white matter hyperintensity volume in the Framingham Study.  Stroke. 2004;  35 1609-1613
  CrossrefPubMedGoogle Scholar
• 7 Fox C S, Polak J F, Chazaro I et al.. Genetic and environmental contributions to atherosclerosis phenotypes in men and women: heritability of carotid intima-media thickness in the Framingham Heart Study.  Stroke. 2003;  34 397-401
  CrossrefPubMedGoogle Scholar
• 8 Juo S H, Lin H F, Rundek T et al.. Genetic and environmental contributions to carotid intima-media thickness and obesity phenotypes in the Northern Manhattan Family Study.  Stroke. 2004;  35 2243-2247
  CrossrefPubMedGoogle Scholar
• 9 Lange L A, Bowden D W, Langefeld C D et al.. Heritability of carotid artery intima-medial thickness in type 2 diabetes.  Stroke. 2002;  33 1876-1881
  CrossrefPubMedGoogle Scholar
• 10 Hunt K J, Duggirala R, Goring H H et al.. Genetic basis of variation in carotid artery plaque in the San Antonio Family Heart Study.  Stroke. 2002;  33 2775-2780
  CrossrefPubMedGoogle Scholar
• 11 Moskau S, Golla A, Grothe C et al.. Heritability of carotid artery atherosclerotic lesions: an ultrasound study in 154 families.  Stroke. 2005;  36 5-8
  PubMedGoogle Scholar
• 12 Zureik M, Ducimetiere P, Touboul P J et al.. Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: longitudinal results from the Aging Vascular Study (EVA) study.  Arterioscler Thromb Vasc Biol. 2000;  20 1622-1629
  PubMedGoogle Scholar
• 13 Adams Jr H P, Bendixen B H, Kappelle L J et al.. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. TOAST-Trial of Org 10172 in Acute Stroke Treatment.  Stroke. 1993;  24 35-41
  CrossrefPubMedGoogle Scholar
• 14 The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators . Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial.  JAMA. 1998;  279 1265-1272
  CrossrefPubMedGoogle Scholar
• 15 Adams Jr H P, Woolson R F, Clarke W R et al.. Design of the Trial of Org 10172 in Acute Stroke Treatment (TOAST).  Control Clin Trials. 1997;  18 358-377
  PubMedGoogle Scholar
• 16 Barnett H J, Taylor D W, Eliasziw M et al.. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators.  N Engl J Med. 1998;  339 1415-1425
  CrossrefPubMedGoogle Scholar
• 17 Hart R G. Prevention of stroke in atrial fibrillation: an update.  Health Rep. 1994;  6 126-131
  PubMedGoogle Scholar
• 18 Kunitz S C, Gross C R, Heyman A et al.. The pilot Stroke Data Bank: definition, design, and data.  Stroke. 1984;  15 740-746
  PubMedGoogle Scholar
• 19 Bogousslavsky J, Van Melle G, Regli F. The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke.  Stroke. 1988;  19 1083-1092
  CrossrefPubMedGoogle Scholar
• 20 Caplan L R, Hier D B, D'Cruz I. Cerebral embolism in the Michael Reese Stroke Registry.  Stroke. 1983;  14 530-536
  PubMedGoogle Scholar
• 21 Mohr J P, Caplan L R, Melski J W et al.. The Harvard Cooperative Stroke Registry: a prospective registry.  Neurology. 1978;  28 754-762
  CrossrefPubMedGoogle Scholar
• 22 Spitzer K, Becker V, Thie A et al.. The Hamburg Stroke Data Bank: goals, design and preliminary results.  J Neurol. 1989;  236 139-144
  PubMedGoogle Scholar
• 23 Gordon D L, Bendixen B H, Adams Jr H P et al.. Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke: implications for clinical trials. The TOAST Investigators.  Neurology. 1993;  43 1021-1027
  PubMedGoogle Scholar
• 24 Madden K P, Karanjia P N, Adams Jr H P et al.. Accuracy of initial stroke subtype diagnosis in the TOAST study. Trial of ORG 10172 in Acute Stroke Treatment.  Neurology. 1995;  45 1975-1979
  CrossrefPubMedGoogle Scholar
• 25 Lee L J, Kidwell C S, Alger J et al.. Impact on stroke subtype diagnosis of early diffusion-weighted magnetic resonance imaging and magnetic resonance angiography.  Stroke. 2000;  31 1081-1089
  PubMedGoogle Scholar
• 26 Goldstein L B, Jones M R, Matchar D B et al.. Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria.  Stroke. 2001;  32 1091-1097
  PubMedGoogle Scholar
• 27 Adams Jr H P, Davis P H, Leira E C et al.. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST).  Neurology. 1999;  53 126-131
  CrossrefPubMedGoogle Scholar
• 28 Lyden P, Brott T, Tilley B et al.. Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group.  Stroke. 1994;  25 2220-2226
  CrossrefPubMedGoogle Scholar
• 29 Lovblad K O, Baird A E, Schlaug G et al.. Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome.  Ann Neurol. 1997;  42 164-170
  CrossrefPubMedGoogle Scholar
• 30 Schulz U G, Flossmann E, Rothwell P M. Heritability of ischemic stroke in relation to age, vascular risk factors, and subtypes of incident stroke in population-based studies.  Stroke. 2004;  35 819-824
  CrossrefPubMedGoogle Scholar
• 31 Meschia J F, Brott T G, Brown Jr R D et al.. The Ischemic Stroke Genetics Study (ISGS) protocol.  BMC Neurol. 2003;  3 4
  CrossrefPubMedGoogle Scholar
• 32 Johnson C J, Kittner S J, McCarter R J et al.. Interrater reliability of an etiologic classification of ischemic stroke.  Stroke. 1995;  26 46-51
  PubMedGoogle Scholar
• 33 Kittner S J, Stern B J, Wozniak M et al.. Cerebral infarction in young adults: the Baltimore-Washington Cooperative Young Stroke Study.  Neurology. 1998;  50 890-894
  CrossrefPubMedGoogle Scholar
• 34 Meschia J F. Addressing the heterogeneity of the ischemic stroke phenotype in human genetics research.  Stroke. 2002;  33 2770-2774
  CrossrefPubMedGoogle Scholar
• 35 Martiskainen M, Pohjasvaara T, Mikkelsson J et al.. Fibrinogen gene promoter -455 A allele as a risk factor for lacunar stroke.  Stroke. 2003;  34 886-891
  CrossrefPubMedGoogle Scholar
• 36 Myllykangas L, Polvikoski T, Sulkava R et al.. Association of lipoprotein lipase Ser447Ter polymorphism with brain infarction: a population-based neuropathological study.  Ann Med. 2001;  33 486-492
  PubMedGoogle Scholar
• 37 Gretarsdottir S, Sveinbjornsdottir S, Jonsson H H et al.. Localization of a susceptibility gene for common forms of stroke to 5q12.  Am J Hum Genet. 2002;  70 593-603
  CrossrefPubMedGoogle Scholar
• 38 Gretarsdottir S, Thorleifsson G, Reynisdottir S T et al.. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke.  Nat Genet. 2003;  35 131-138
  PubMedGoogle Scholar
• 39 Funalot B, Varenne O, Mas J L. A call for accurate phenotype definition in the study of complex disorders.  Nat Genet. 2004;  36 3 , author reply 3-4
  PubMedGoogle Scholar
• 40 Furlan A, Higashida R, Wechsler L et al.. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism.  JAMA. 1999;  282 2003-2011
  CrossrefPubMedGoogle Scholar
• 41 Uchino K, Billheimer D, Cramer S C. Entry criteria and baseline characteristics predict outcome in acute stroke trials.  Stroke. 2001;  32 909-916
  PubMedGoogle Scholar
• 42 Casas J P, Hingorani A D, Bautista L E et al.. Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls.  Arch Neurol. 2004;  61 1652-1661
  CrossrefPubMedGoogle Scholar
• 43 http://locus.umdnj.edu/ninds Accessed March 11, 2005
• 44 Foulkes M A, Wolf P A, Price T R et al.. The Stroke Data Bank: design, methods, and baseline characteristics.  Stroke. 1988;  19 547-554
  CrossrefPubMedGoogle Scholar
• 45 Bamford J, Sandercock P, Dennis M et al.. Classification and natural history of clinically identifiable subtypes of cerebral infarction.  Lancet. 1991;  337 1521-1526
  CrossrefPubMedGoogle Scholar
• 46 Markus H S, Barley J, Lunt R et al.. Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma.  Stroke. 1995;  26 1329-1333
  PubMedGoogle Scholar
• 47 Ito D, Murata M, Watanabe K et al.. C242T polymorphism of NADPH oxidase p22 PHOX gene and ischemic cerebrovascular disease in the Japanese population.  Stroke. 2000;  31 936-939
  PubMedGoogle Scholar
• 48 Kokubo Y, Chowdhury A H, Date C et al.. Age-dependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population.  Stroke. 2000;  31 1299-1306
  PubMedGoogle Scholar
• 49 Kessler C, Spitzer C, Stauske D et al.. The apolipoprotein E and beta-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease.  Arterioscler Thromb Vasc Biol. 1997;  17 2880-2884
  PubMedGoogle Scholar
• 50 Jannes J, Hamilton-Bruce M A, Pilotto L et al.. Tissue plasminogen activator -7351C/T enhancer polymorphism is a risk factor for lacunar stroke.  Stroke. 2004;  35 1090-1094
  CrossrefPubMedGoogle Scholar

James F MeschiaM.D. 

Department of Neurology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224